Table 2 Baseline characteristics across C3 complement levels group
Variables | Decrease C3 level, n = 48 | Normal C3 Level, n = 72 | P value |
|---|---|---|---|
Age (years), median (IQR) | 29 (15,5) | 31 (13,5) | 0,69 |
Marital Status | |||
Married | 26 (54,1%) | 37 (51,4%) | 0,304 |
Unmarried | 20 (41,67%) | 33 (45,8%) | |
Divorced | 2 (4,17%) | 2 (2,78%) | |
Steroid duration (week), median (IQR) | 16 (23) | 16 (31) | 0,736 |
Lupus activity (MEX SLEDAI), median (IQR) | 8,5 (8,75) | 6 (6) | 0,057 |
HADS A score (Anxiety), median (IQR) | 6 (5) | 5 (5) | 0,157 |
HADS D score (Depression), median (IQR) | 6 (4) | 6(2) | 0,406 |
Organ Involvement, n (%) | |||
Mucocutaneous | 46 (95,8%) | 70 (97,2%) | 1 |
Musculoskeletal | 45 (93,8%) | 69(95,8%) | 0,68 |
Hematology | 24 (50%) | 34 (47,2%) | 0,037 |
Kidney | 30 (62,5%) | 31 (43%) | 0,037 |
Serositis | 5 (10,4%) | 4 (5,5%) | 0,481 |
DMARD | |||
Azathioprine | 12 (25%) | 10 (13,9) | 0,123 |
Cyclosporine | 2 (4,2%) | 7 (9,7%) | 0,313 |
HCQ | 34 (70,8%) | 53 (73,6%) | 0,738 |
Mycophenolate | 28 (58,3%) | 38 (52,7%) | 0,549 |
MTX | 0 | 0 | NA |
Tacrolimus | 0 | 1 (1,4%) | 1 |